David B Goldstein

Title: The Innovations of David B Goldstein

Introduction

David B Goldstein is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of genetics, particularly in understanding the response to interferon-alpha treatment. His work has implications for patient care and treatment selection in various diseases.

Latest Patents

Goldstein holds a patent for "Genetic markers associated with interferon-alpha response." This invention provides genetic markers located on human chromosome 19 that are linked to a beneficial response to interferon alpha (IFN-α). These markers are instrumental in identifying patients who are likely to benefit from IFN-α pharmaceutical compositions and drug products. The patent outlines methods for treating patients with diseases that are susceptible to IFN-α treatment and for selecting the most appropriate therapy for these patients. He has 1 patent to his name.

Career Highlights

Goldstein is associated with Merck Sharp & Dohme Corp., where he continues to advance research in his field. His work has been pivotal in enhancing the understanding of genetic factors that influence treatment responses.

Collaborations

He has collaborated with notable researchers such as Jacques Fellay and John G McHutchison, contributing to a broader understanding of genetic markers and their clinical applications.

Conclusion

David B Goldstein's innovative work in genetics and his patent on interferon-alpha response markers highlight his significant contributions to medical science. His research continues to impact patient treatment strategies and improve healthcare outcomes.